within Pharmacolibrary.Drugs.H_SystemicHormonalPreparationsExclSexHormonesAndInsulins.H01A_AnteriorPituitaryLobeHormonesAndAnalogues.H01AC09_Lonapegsomatropin;
model Lonapegsomatropin 
   extends Pharmacolibrary.Drugs.ATC.H.H01AC09;

  annotation(Documentation(
    info ="<html><body><p>Lonapegsomatropin is a long-acting prodrug of somatropin (recombinant human growth hormone) designed for once-weekly subcutaneous administration to treat pediatric patients with growth hormone deficiency. It is FDA and EMA approved for pediatric and adolescent use.</p><h4>Pharmacokinetics</h4><p>Population pharmacokinetics in pediatric patients with growth hormone deficiency based on two-compartment model with first-order absorption following subcutaneous injection.</p><h4>References</h4><ol></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end Lonapegsomatropin;
